The Revenue for the quarter ended  March 2022 of Rs. 735.99 millions grew by 23.71 % from Rs. 594.93 millions.The Profit  for the quarter ended March 2022 of  Rs. 118.76  millions  grew by 53.30% from Rs. 77.47 millions.Operating profit surged to 234.91 millions from the corresponding previous quarter of 168.98 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 735.99 594.93 23.71 2759.80 2090.51 32.02 2759.80 2090.51 32.02
Other Income 4.19 2.38 76.05 14.54 8.10 79.51 14.54 8.10 79.51
PBIDT 234.91 168.98 39.02 812.26 535.01 51.82 812.26 535.01 51.82
Interest 5.74 6.78 -15.34 14.96 21.67 -30.96 14.96 21.67 -30.96
PBDT 229.17 162.20 41.29 785.06 513.34 52.93 785.06 513.34 52.93
Depreciation 66.44 57.87 14.81 231.58 229.37 0.96 231.58 229.37 0.96
PBT 162.73 104.33 55.98 553.48 283.97 94.91 553.48 283.97 94.91
TAX 43.97 26.86 63.70 142.90 71.37 100.22 142.90 71.37 100.22
Deferred Tax 5.40 4.80 12.50 -10.33 -4.89 111.25 -10.33 -4.89 111.25
PAT 118.76 77.47 53.30 410.58 212.60 93.12 410.58 212.60 93.12
Equity 44.22 44.22 0.00 44.22 44.22 0.00 44.22 44.22 0.00
PBIDTM(%) 31.92 28.40 12.37 29.43 25.59 15.00 29.43 25.59 15.00

Vimta Labs Share Price

545.85 -12.85 (-2.30%)
26-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1504.25
Dr. Reddys Lab 6263.70
Cipla 1406.25
Zydus Lifesciences 948.20
Lupin 1615.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.